DocWire News Editors

DocwireNews

A remotely delivered multicomponent intervention behaviorally tailored to each patient improved medication adherence, but&nbsp;not&nbsp;clinical outcomes, results of the STIC2IT trial suggested.&nbsp;The study,&nbsp;published in&nbsp;Annals of Internal Medicine,&nbsp;looked at 4,078 adults with poorly&nbsp;controlled&nbsp;disease (hyperlipidemia,&nbsp;<a class="Hyperlink SCXW157420640" href="https://proddocwire.wpengine.com/docwire-pick/future-of-medicine-picks/microsoft-patent-blood-pressure-sensing-glasses/" target="_blank" rel="noopener noreferrer">hypertension</a>&nbsp;and&nbsp;<a class="Hyperlink SCXW157420640" href="https://proddocwire.wpengine.com/cardiology/4794553/" target="_blank" rel="noopener noreferrer">diabetes</a>) who were also nonadherent to medication. Patients received either a tailored intervention that included telephone-delivered&nbsp;behavioral&nbsp;interviewing by pharmacists, pill boxes, text messages and progress reports, or usual care. Seven of the study&rsquo;s 14 sites were&nbsp;randomized&nbsp;to the intervention.&nbsp;The&nbsp;primary study outcome was medication adherence via pharmacy claims data.&nbsp;<a href="https://twitter.com/anupam1623/statuses/1027238051024646144">https://twitter.com/anupam1623/statuses/1027238051024646144</a>According&nbsp;to the&nbsp;results, the&nbsp;tailored&nbsp;intervention was associated with a 4.7% (95% CI, 3.0%-6.4%) improvement in medication adherence compared to usual care. There were no differences in the odds of achieving adequate disease control, however, for at least one or&nbsp;all of&nbsp;the patient conditions. Patients receiving the intervention were less likely to have an emergency department visit. An as-treated analysis showed that the&nbsp;tailored&nbsp;intervention was associated with a 10.4% adherence increase.&nbsp;&nbsp;&nbsp;&nbsp;A multicomponent,&nbsp;technologically&nbsp;enabled pharmacist intervention&nbsp;tailored&nbsp;to patients&rsquo; adherence barriers and level of health activation improved medication adherence for patients with common, chronic conditions but did not change clinical outcomes,&rdquo; the researchers wrote. &ldquo;Future work should focus on identifying which groups derive the most&nbsp;clinical&nbsp;benefit from adherence to improvement efforts.&rdquo;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Remote pharmacist interventions aid <a href="https://twitter.com/hashtag/chronicillness?src=hash&amp;ref_src=twsrc%5Etfw">#chronicillness</a> management, <a href="https://twitter.com/hashtag/prevent?src=hash&amp;ref_src=twsrc%5Etfw">#prevent</a> hospitalization. <a href="https://twitter.com/FZanjani?ref_src=twsrc%5Etfw">@FZanjani</a> , reminds me of your project. Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes <a href="https://t.co/QD7FDvsJ86">https://t.co/QD7FDvsJ86</a>
&mdash; Cee A. Davis,MD,MPH (@cdBRComHealth) <a href="https://twitter.com/cdBRComHealth/status/1026814474236440578?ref_src=twsrc%5Etfw">August 7, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
A remotely delivered multicomponent behaviorally tailored intervention resulted in a statistically significant increase in medication adherence but did not change clinical outcomes <a href="https://t.co/hPmOgKXRUL">https://t.co/hPmOgKXRUL</a>
&mdash; @investigando (@rocatanho) <a href="https://twitter.com/rocatanho/status/1026697979330211841?ref_src=twsrc%5Etfw">August 7, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Chronic disease management is hard. This multicomponent, tech enabled pharmacist and behavioral intervention modestly improved medication adherence but not clinical outcomes <a href="https://t.co/4sVqnNqDdg">https://t.co/4sVqnNqDdg</a>
&mdash; Joseph Ross (@jsross119) <a href="https://twitter.com/jsross119/status/1026661026517929986?ref_src=twsrc%5Etfw">August 7, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
4.7% &#11014;&#65039; in <a href="https://twitter.com/hashtag/adherence?src=hash&amp;ref_src=twsrc%5Etfw">#adherence</a> vs usual care but no diff in the odds of achieving good dz control for at least 1 or all eligible conditions,hospitalization, or having a physician office visit
Intervention participants were signif &lt; likely to have an ED visit <a href="https://t.co/So07Jkc4lS">https://t.co/So07Jkc4lS</a>
&mdash; John P Erwin III MD MBA FACC (@HeartOTXHeartMD) <a href="https://twitter.com/HeartOTXHeartMD/status/1026590147641409536?ref_src=twsrc%5Etfw">August 6, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes <a href="https://t.co/A5VCW5TmX4">https://t.co/A5VCW5TmX4</a> Good intervention with a minimal result.
&mdash; Mark Harmel MPH, CDCES (@MarkHarmel) <a href="https://twitter.com/MarkHarmel/status/1026645351867011072?ref_src=twsrc%5Etfw">August 7, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Source:&nbsp;<a href="https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2695510">JAMA Internal Medicine</a>&nbsp;

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

STIC2IT: Tailored Medication Intervention Improves Adherence

Cardiology

A remotely delivered multicomponent intervention behaviorally tailored to each patient improved medication adherence, but not clinical outcomes, results of the STIC2IT trial ...